Hallucinogenic drug use and depression, psychological distress and suicidality among disabled adults in the US
Addictive Behaviors · 2025
DOI: 10.1016/j.addbeh.2025.108454 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addictive Behaviors, 2025. Verfasst von Samantha M Ross-Cypcar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Special Education, College of Education, University of Utah, United States. Electronic address: samantha.ross@utah.edu. Hauptthemen laut MEDLINE: Hallucinogens, Persons with Disabilities, Psychological Distress, Depression. Die Arbeit nennt 31 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
While recent nationally representative studies have evaluated the association between hallucinogen use and mental health events, little is known about these associations among disabled adults. Our primary aim was to use national data from the 2021, 2022, and 2023 National Survey on Drug Use and Health (NSDUH) to determine how past-year use of specific hallucinogens is associated with disabled adults reporting past-year SPD, MDE, and suicidality. A subsample of adults ages 18 to 50 years old (n = 107,781) was drawn from the 2021-2023 combined NSDUH dataset for this analysis. Descriptive analyzes generated weighted prevalence estimates for hallucinogen use and mental health outcomes, and crude odds ratios for experiencing a mental health outcome among past year hallucinogen users were estimated in comparison to non-hallucinogen users, stratified by disability status. The weighted prevalence of hallucinogen use in the past year was significantly higher among disabled (8.37 %) compared to nondisabled adults (4.86 %; p < 0.0001). Among disabled adults who used hallucinogens in the past year, 48.87 % reported a major depressive episode, 68.93 % reported a serious psychological distress indicator, and 39.65 % reported suicidal thinking, planning, or attempt. About 4 % of disabled adults reported that hallucinogen use in the past year worsened or caused emotional or mental health problems. Findings provide evidence of differences to the degree that disabled adults are using hallucinogens in comparison to nondisabled adults using a nationally representative sample. These findings provide new data to help understand hallucinogen use in relation to mental health events among this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Special Education, College of Education, University of Utah, United States. Electronic address: samantha.ross@utah.edu.
- Department of Human Movement Studies & Special Education, Old Dominion University, United States. Electronic address: jhaegele@odu.edu.
- School of Sport Sciences, West Virginia University, United States. Electronic address: Jeanette.garcia@mail.wvu.edu.
Zitieren
APA
Ross-Cypcar, S. M., Haegele, J. A., & Garcia, J. M. (2025). Hallucinogenic drug use and depression, psychological distress and suicidality among disabled adults in the US. Addictive Behaviors. https://doi.org/10.1016/j.addbeh.2025.108454
Vancouver
Ross-Cypcar SM, Haegele JA, Garcia JM. Hallucinogenic drug use and depression, psychological distress and suicidality among disabled adults in the US. Addictive Behaviors. 2025. doi:10.1016/j.addbeh.2025.108454
BibTeX
@article{RossCypcar2025,
author = {Ross-Cypcar, Samantha M and Haegele, Justin A and Garcia, Jeanette M},
title = {Hallucinogenic drug use and depression, psychological distress and suicidality among disabled adults in the US},
journal = {Addictive Behaviors},
year = {2025},
doi = {10.1016/j.addbeh.2025.108454}
}
EUVIMED